COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 79 filers reported holding COHERUS BIOSCIENCES INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $2,641,000 | +356.1% | 124,900 | +506.3% | 0.17% | +247.9% |
Q4 2016 | $579,000 | -74.5% | 20,600 | -75.7% | 0.05% | -73.9% |
Q3 2016 | $2,273,000 | -27.4% | 84,900 | -54.2% | 0.18% | -37.2% |
Q2 2016 | $3,131,000 | +1059.6% | 185,400 | +1879.3% | 0.29% | +671.1% |
Q2 2015 | $270,000 | – | 9,367 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
Knott David M Jr | 630,000 | $2,356 | 0.90% |
COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |